IFNλ1-neutralizing antibodies inhibited the STINGa-ADC-mediated cancer cell-killing activity and induction of IFNβ and other cytokines/chemokines in cancer/immune cell co-cultures, which was partially rescued by the addition of recombinant IFNβ protein. The gene discussed is IFNL1; the disease is cancer.